Metformin is associated with a lower risk of active tuberculosis in patients with type 2 diabetes.

Shang-Yi LinHung-Pin TuPo-Liang LuTun-Chieh ChenWen-Hung WangInn-Wen ChongYen-Hsu Chen

Published in: Respirology (Carlton, Vic.) (2018)

Among all types of ADT and insulin therapies, metformin is the only agent with a decreased risk of active TB in the T2DM population. However, this effect was diminished in the elderly population and was not observed in patients with metabolic disorders.

Keyphrases

mycobacterium tuberculosis
type diabetes
glycemic control
emergency department
metabolic syndrome
skeletal muscle
adipose tissue
community dwelling